In the latest trading session,, 2.56 million Clearmind Medicine Inc (NASDAQ:CMND) shares changed hands as the company’s beta touched -1.27. With the company’s most recent per share price at $1.17 changing hands around $0.17 or 17.00% at last look, the market valuation stands at $6.29M. CMND’s current price is a discount, trading about -86.32% off its 52-week high of $2.18. The share price had its 52-week low at $0.80, which suggests the last value was 31.62% up since then. When we look at Clearmind Medicine Inc’s average trading volume, we note the 10-day average is 0.24 million shares, with the 3-month average coming to 793.73K.

Clearmind Medicine Inc (NASDAQ:CMND) trade information

Instantly CMND is in green as seen in intraday trades today. With action 18.33%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -33.52%, with the 5-day performance at 18.33% in the green. However, in the 30-day time frame, Clearmind Medicine Inc (NASDAQ:CMND) is 36.05% up. Looking at the short shares, we see there were 0.12 million shares sold at short interest cover period of 1.04 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 23.39%.

CMND Dividends

Clearmind Medicine Inc is expected to release its next quarterly earnings report in August.

Clearmind Medicine Inc (NASDAQ:CMND)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 2.80% of Clearmind Medicine Inc shares while 11.19% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 11.51%.

With 205.93 shares estimated at $0.24 million under it, the former controlled 4.83% of total outstanding shares.